查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447087

到 2030 年胆固醇测试市场预测：按产品类型、测试类型、分销管道、最终用户和地区进行的全球分析

Cholesterol Test Market Forecasts to 2030 - Global Analysis By Product Type, Test Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球胆固醇检测市场规模将达到 68.4 亿美元，预计到 2030 年将达到 135 亿美元，预测期内复合年增长率为 10.3%。

胆固醇测试是一种旨在测量血液中胆固醇水平的诊断程序。评估各种类型的胆固醇，包括低密度脂蛋白 (LDL)、高密度脂蛋白 (HDL) 和三酸甘油酯，对于评估心血管健康至关重要。胆固醇测试通常透过抽血进行，以帮助识别有心臟病或经历心血管事件风险的人。

据世界卫生组织 (WHO) 称，到 2022 年，将有超过 6.5 亿成年人患有肥胖症。

心血管疾病盛行率上升

心血管疾病，包括心臟病发作和中风，是全世界发病和死亡的主要原因。高胆固醇水平是这些疾病的主要危险因子。随着心血管疾病盛行率持续上升，胆固醇检测的需求也随之增加。胆固醇测试有助于评估各种胆固醇成分的水平，包括低密度脂蛋白（LDL）胆固醇、高密度脂蛋白（HDL）胆固醇和三酸甘油酯。整体而言，心血管疾病盛行率的上升是推动市场需求的因素。

高成本

与胆固醇检测相关的高昂费用，包括实验室检测、诊断设备和专业费用，造成了经济障碍，特别是对于保险不足或无法获得医疗保健服务的人来说。此外，医疗保健提供者还面临着平衡提供负担得起的测试选项的需求与保持盈利和支付营运费用的挑战。因此，高成本对胆固醇检测市场构成重大威胁。

技术进步

新型生物标记和多重测试平台的整合实现了全面的血脂分析，从而可以对传统胆固醇测量之外的心血管危险因素进行更全面的评估。此外，基于实验室的胆固醇检测技术的进步引入了自动化分析仪和高通量系统，提高了检测效率和扩充性，同时减少了人为错误和营运成本。

认识有限

许多人没有意识到胆固醇检测在评估心臟病和中风风险的重要性，无症状族群的检测率特别低。此外，对胆固醇检测程序的误解和错误讯息、感知的侵入性以及与抽血相关的不适可能会进一步阻碍人们接受检测。因此，认知度低是限制市场拓展的主要因素。

COVID-19 的影响

COVID-19 的疫情对胆固醇检测市场产生了负面影响。最初，医疗保健系统的重点转向危机管理，导致常规医疗服务中断，包括胆固醇检测和预防性护理。许多非紧急医疗预约已被推迟或取消，导致胆固醇检测减少。此外，出于对病毒传播的担忧，除非绝对必要，否则人们会避开医疗机构，这进一步减少了接受胆固醇检测的人数。

检测套组细分市场在预测期内将是最大的

检测套组部分估计占最大份额。这些套件通常包含在传统实验室之外进行胆固醇测试所需的所有组件。它通常包含试纸、采血采血针以及分析所需的溶液和试剂。医疗保健提供者还利用胆固醇检测套组在患者就诊和体检期间进行快速评估。此外，这些套件可快速提供结果，以便及时做出介入和治疗决策。

总胆固醇检测领域预计在预测期内复合年增长率最高

预计总胆固醇检测领域在预测期内将出现良好的成长。此测试测量血液中胆固醇的总量，包括高密度脂蛋白（HDL）胆固醇和低密度脂蛋白（LDL）胆固醇以及三酸甘油酯。总胆固醇测试在预防性医疗保健中发挥重要作用，为了解个人的血脂状况和整体心血管健康提供了宝贵的见解。

比最大的地区

由于强大的医疗基础设施、先进的诊断技术和心血管疾病危险因子的高盛行率，北美在预测期内占据了最大的市场占有率。该地区是许多製药和生物技术公司的所在地，这些公司开发创新的降胆固醇药物和诊断技术，推动市场成长和创新。此外，公共卫生宣传活动和教育工作提高了人们对胆固醇管理和健康生活方式选择重要性的认识，进一步增加了对胆固醇检测服务和产品的需求。

复合年增长率最高的地区：

预计亚太地区在预测期内将实现盈利成长。亚太地区国家正在经历人口变化，例如人口老化和可支配收入较高的中产阶级的出现，推动了对包括胆固醇检测在内的医疗保健服务的需求。此外，旨在解决非传染性疾病的政府倡议，例如心血管健康促进和疾病预防计划，正在进一步推动该地区的市场成长。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球胆固醇测试市场：依产品类型

  • 试纸
  • 检测套组
  • 检验仪
  • 其他产品类型

第六章全球胆固醇测试市场：依测试类型

  • 高密度脂蛋白（HDL）胆固醇
  • 低密度脂蛋白（LDL）胆固醇
  • 总胆固醇测试
  • 三酸甘油酯/VLDL胆固醇测试
  • 其他测试类型

第七章全球胆固醇测试市场：按分销管道

  • 在商店
  • 基于处方笺

第八章全球胆固醇测试市场：依最终用户分类

  • 居家照护
  • 医院和诊所
  • 诊断中心
  • 其他最终用户

第九章全球胆固醇测试市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Thermo Fisher Scientific
  • Cell Biolabs, Inc.
  • Randox Laboratories Ltd.
  • Clinical Reference Laboratory, Inc.
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Alere Inc.
  • PTS Diagnostics
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Horiba Ltd
  • Danaher Corp
  • Abbott Laboratories
  • Nova Biomedical
Product Code: SMRC25348

According to Stratistics MRC, the Global Cholesterol Test Market is accounted for $6.84 billion in 2023 and is expected to reach $13.5 billion by 2030 growing at a CAGR of 10.3% during the forecast period. A cholesterol test is a diagnostic procedure aimed at measuring the levels of cholesterol in the blood. It assesses various types of cholesterol, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides, which are essential for evaluating cardiovascular health. Typically conducted through a blood sample, cholesterol testing helps identify individuals at risk of developing heart disease or experiencing cardiovascular events.

According to the World Health Organization (WHO), in 2022, over 650 million adults were obese.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular diseases

Cardiovascular diseases, including heart attacks and strokes, are leading causes of morbidity and mortality globally. High cholesterol levels are a major risk factor for these diseases. As the prevalence of cardiovascular diseases continues to rise, there is a growing need for cholesterol testing. Cholesterol testing helps in assessing the levels of different cholesterol components, such as low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. Overall, the rising prevalence of cardiovascular diseases is a factor driving market demand.

Restraint:

High cost

The high costs associated with cholesterol testing procedures, including laboratory tests, diagnostic equipment, and professional fees, can create financial barriers for individuals, particularly those without adequate insurance coverage or access to healthcare services. Moreover, healthcare providers face challenges in balancing the need to provide affordable testing options with maintaining profitability and covering operational expenses. As a result, high costs present a significant threat to the cholesterol test market.

Opportunity:

Technological advancements

The integration of novel biomarkers and multiplex testing platforms enables comprehensive lipid profiling, providing a more holistic assessment of cardiovascular risk factors beyond traditional cholesterol measurements. Furthermore, advancements in laboratory-based cholesterol testing technologies have led to the introduction of automated analyzers and high-throughput systems, enhancing testing efficiency and scalability while reducing human error and operational costs.

Threat:

Limited awareness

Many individuals remain unaware of the importance of cholesterol testing in assessing their risk of heart disease and stroke, leading to low testing rates, especially among asymptomatic individuals. Additionally, misconceptions or misinformation about cholesterol testing procedures, perceived invasiveness, or discomfort associated with blood draws may further deter individuals from seeking testing. Therefore, limited awareness is a significant factor limiting market expansion.

Covid-19 Impact

The COVID-19 pandemic had a negative impact on the cholesterol test market. Initially, the focus of healthcare systems shifted towards managing the crisis, leading to disruptions in routine medical services, including cholesterol testing and preventive care. Many non-urgent medical appointments were postponed or cancelled, resulting in a decline in cholesterol screenings. Additionally, concerns about virus transmission prompted individuals to avoid healthcare facilities unless absolutely necessary, further reducing the number of people seeking cholesterol tests.

The test kits segment is expected to be the largest during the forecast period

The test kits segment is estimated to hold the largest share. These kits typically contain all the necessary components for conducting cholesterol tests outside of traditional laboratory settings. They often include test strips, lancets for blood sampling, and solutions or reagents required for analysis. Healthcare providers also rely on cholesterol test kits for rapid assessments during patient consultations or health screenings. Additionally, these kits offer quick results, allowing for timely interventions and treatment decisions.

The total cholesterol test segment is expected to have the highest CAGR during the forecast period

The total cholesterol test segment is anticipated to have lucrative growth during the forecast period. This test measures the total amount of cholesterol present in the blood, including both high-density lipoprotein (HDL) cholesterol and low-density lipoprotein (LDL) cholesterol, along with triglycerides. The total cholesterol test plays a critical role in preventive healthcare, providing valuable insights into an individual's lipid profile and overall cardiovascular health status.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to the robust healthcare infrastructure, advanced diagnostic technologies, and a high prevalence of cardiovascular disease risk factors. The region is home to numerous pharmaceutical and biotechnology companies engaged in developing innovative cholesterol-lowering medications and diagnostic technologies, driving market growth and innovation. Additionally, public health campaigns and educational efforts raise awareness about the importance of cholesterol management and healthy lifestyle choices, further driving demand for cholesterol testing services and products.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. Countries in the Asia Pacific region are experiencing demographic shifts, including aging populations and the emergence of a middle-class segment with greater disposable income, driving demand for healthcare services, including cholesterol testing. Additionally, government initiatives aimed at addressing non-communicable diseases, including cardiovascular health promotion and disease prevention programs, further propel market growth in this region.

Key players in the market

Some of the key players in the Cholesterol Test Market include Thermo Fisher Scientific, Cell Biolabs, Inc., Randox Laboratories Ltd., Clinical Reference Laboratory, Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Alere Inc., PTS Diagnostics, Eurofins Scientific, F. Hoffmann-La Roche AG, Horiba Ltd, Danaher Corp, Abbott Laboratories and Nova Biomedical.

Key Developments:

In December 2023, Randox Laboratories Ltd and Transgene entered into a scientific collaboration, with the aim of joining their competences to deliver a novel therapeutic approach to oncology therapies.

In May 2023, Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of Indonesia (BRIN, Badan Riset dan Inovasi Nasional) to enable and enhance the country's national research and innovation infrastructure and capability.

In February 2023, Roche announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to create companion diagnostics for targeted therapies, further strengthening research and innovation activities.

In November 2022, Danaher Corporation, a global science and technology innovator, announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation.

Product Types Covered:

  • Test Strips
  • Test Kits
  • Test Meters
  • Other Product Types

Test Types Covered:

  • High-Density Lipoprotein (HDL) Cholesterol
  • Low-Density Lipoprotein (LDL) Cholesterol
  • Total Cholesterol Test
  • Triglycerides/VLDL Cholesterol Test
  • Other Test Types

Distribution Channels Covered:

  • Over the Counter
  • Prescription Based

End Users Covered:

  • Homecare
  • Hospitals & Clinics
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cholesterol Test Market, By Product Type

  • 5.1 Introduction
  • 5.2 Test Strips
  • 5.3 Test Kits
  • 5.4 Test Meters
  • 5.5 Other Product Types

6 Global Cholesterol Test Market, By Test Type

  • 6.1 Introduction
  • 6.2 High-Density Lipoprotein (HDL) Cholesterol
  • 6.3 Low-Density Lipoprotein (LDL) Cholesterol
  • 6.4 Total Cholesterol Test
  • 6.5 Triglycerides/VLDL Cholesterol Test
  • 6.6 Other Test Types

7 Global Cholesterol Test Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Over the Counter
  • 7.3 Prescription Based

8 Global Cholesterol Test Market, By End User

  • 8.1 Introduction
  • 8.2 Homecare
  • 8.3 Hospitals & Clinics
  • 8.4 Diagnostic Centers
  • 8.5 Other End Users

9 Global Cholesterol Test Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Thermo Fisher Scientific
  • 11.2 Cell Biolabs, Inc.
  • 11.3 Randox Laboratories Ltd.
  • 11.4 Clinical Reference Laboratory, Inc.
  • 11.5 Quest Diagnostics Incorporated
  • 11.6 Laboratory Corporation of America Holdings
  • 11.7 Alere Inc.
  • 11.8 PTS Diagnostics
  • 11.9 Eurofins Scientific
  • 11.10 F. Hoffmann-La Roche AG
  • 11.11 Horiba Ltd
  • 11.12 Danaher Corp
  • 11.13 Abbott Laboratories
  • 11.14 Nova Biomedical

List of Tables

  • Table 1 Global Cholesterol Test Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 4 Global Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 5 Global Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 6 Global Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 7 Global Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 8 Global Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 9 Global Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 10 Global Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 11 Global Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 12 Global Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 13 Global Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 14 Global Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 15 Global Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 16 Global Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 18 Global Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 19 Global Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 20 Global Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 21 North America Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
  • Table 22 North America Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 23 North America Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 24 North America Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 25 North America Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 26 North America Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 27 North America Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 28 North America Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 29 North America Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 30 North America Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 31 North America Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 32 North America Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 33 North America Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 34 North America Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 35 North America Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 36 North America Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 37 North America Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 38 North America Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 39 North America Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 40 North America Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 41 Europe Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Europe Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 43 Europe Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 44 Europe Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 45 Europe Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 46 Europe Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 47 Europe Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 48 Europe Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 49 Europe Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 50 Europe Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 51 Europe Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 52 Europe Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 53 Europe Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 54 Europe Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 55 Europe Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 56 Europe Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 57 Europe Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 58 Europe Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 59 Europe Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 60 Europe Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Asia Pacific Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Asia Pacific Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 63 Asia Pacific Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 64 Asia Pacific Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 65 Asia Pacific Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 66 Asia Pacific Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 67 Asia Pacific Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 68 Asia Pacific Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 69 Asia Pacific Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 70 Asia Pacific Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 71 Asia Pacific Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 72 Asia Pacific Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 73 Asia Pacific Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 74 Asia Pacific Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 75 Asia Pacific Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 76 Asia Pacific Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 77 Asia Pacific Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 78 Asia Pacific Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 79 Asia Pacific Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 80 Asia Pacific Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 81 South America Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 South America Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 83 South America Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 84 South America Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 85 South America Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 86 South America Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 87 South America Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 88 South America Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 89 South America Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 90 South America Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 91 South America Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 92 South America Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 93 South America Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 94 South America Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 95 South America Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 96 South America Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 97 South America Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 98 South America Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 99 South America Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 100 South America Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 101 Middle East & Africa Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 Middle East & Africa Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 103 Middle East & Africa Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
  • Table 104 Middle East & Africa Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
  • Table 105 Middle East & Africa Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
  • Table 106 Middle East & Africa Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 107 Middle East & Africa Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 108 Middle East & Africa Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
  • Table 109 Middle East & Africa Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
  • Table 110 Middle East & Africa Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
  • Table 111 Middle East & Africa Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
  • Table 112 Middle East & Africa Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 113 Middle East & Africa Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 114 Middle East & Africa Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
  • Table 115 Middle East & Africa Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
  • Table 116 Middle East & Africa Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
  • Table 117 Middle East & Africa Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
  • Table 118 Middle East & Africa Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 119 Middle East & Africa Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 120 Middle East & Africa Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)